Skip to content

Syqe Medical

Syqe Medical is a Pharma-Tech company developing a precision platform for inhaled CNS drugs.

Last updated September 15, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Syqe Medical is a Pharma-Tech company that describes itself as transforming CNS treatment by separating therapeutic power from impairment, and as offering a first-in-class precision platform for potent CNS drug delivery at home. Its platform includes patented Precision Micro-dosing via a VaporChip enabling pharmaceutical-grade accuracy with 100µg resolution, adjustable by patient or remotely by a physician; patented ActiveFlow and PulseBreath technologies for consistent absorption; pre-loaded, electronically tagged cartridges for secure and tamper-proof use; and integrated cloud connectivity for data-driven adherence tracking. The company also states it operates a commercial paid real-world evidence pilot under localized regulations with SyqeAir. Wikidata describes Syqe Medical as a company that develops technologies for precise administration of medical cannabis.

History

Syqe Medical presents itself as a Pharma-Tech company transforming CNS treatment by separating therapeutic power from impairment, and as offering a first-in-class precision platform for potent CNS drug delivery at home. Its platform combines patented Precision Micro-dosing via a VaporChip enabling pharmaceutical-grade accuracy with 100µg resolution, adjustable by patient or remotely by a physician; patented ActiveFlow and PulseBreath technologies for consistent absorption; pre-loaded, electronically tagged cartridges for secure and tamper-proof use; and integrated cloud connectivity for data-driven adherence tracking. The company states it operates a commercial paid real-world evidence pilot under localized regulations with SyqeAir. Wikidata describes Syqe Medical as a company that develops technologies for precise administration of medical cannabis.

Products and positioning

Pharma-Tech company transforming the future of precision inhaled CNS drugs through a unique innovative inhalation platform.

  • Precision Platform for Inhaled CNS Drugs

    A first-in-class precision platform for potent CNS drug delivery at home.

  • VaporChip

    Patented technology enabling pharmaceutical-grade accuracy with 100µg resolution, adjustable by patient or remotely by a physician.

  • ActiveFlow and PulseBreath

    Patented technologies ensuring repeatable doses that provide uniform absorption across various inhalation patterns.

  • SyqeAir

    Used in a commercial paid real-world evidence pilot under localized regulations.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/syqe-medical · Editorial policy · How profiles are compiled